Anti-Nanog antibody - ChIP Grade (ab21624)

ab21624 has been referenced in 19 publications.

1. Hatano SY et al. Pluripotential competence of cells associated with Nanog activity. Mech Dev 122:67-79 (2005). PubMed: 15582778
2. Yamaguchi S et al. Nanog expression in mouse germ cell development. Gene Expr Patterns 5:639-46 (2005). PubMed: 15939376
3. Cioffi M et al. EpCAM/CD3-Bispecific T-cell engaging antibody MT110 eliminates primary human pancreatic cancer stem cells. Clin Cancer Res 18:465-74 (2012). WB; Human. PubMed: 22096026
4. Liu GH et al. Recapitulation of premature ageing with iPSCs from Hutchinson-Gilford progeria syndrome. Nature 472:221-5 (2011). ICC/IF; Human. PubMed: 21346760
5. Avery S et al. The role of SMAD4 in human embryonic stem cell self-renewal and stem cell fate. Stem Cells 28:863-73 (2010). ICC/IF; Human. PubMed: 20235236
6. Naka N et al. Synovial sarcoma is a stem cell malignancy. Stem Cells 28:1119-31 (2010). ICC/IF; Human. PubMed: 20518020
7. Oda Y et al. Induction of pluripotent stem cells from human third molar mesenchymal stromal cells. J Biol Chem 285:29270-8 (2010). ICC/IF; Human. PubMed: 20595386
8. Maehr R et al. Generation of pluripotent stem cells from patients with type 1 diabetes. Proc Natl Acad Sci U S A 106:15768-73 (2009). ICC/IF; Human. PubMed: 19720998
9. Chan KK et al. KLF4 and PBX1 directly regulate NANOG expression in human embryonic stem cells. Stem Cells 27:2114-25 (2009). WB, ChIP; Human. PubMed: 19522013
10. Page RL et al. Induction of stem cell gene expression in adult human fibroblasts without transgenes. Cloning Stem Cells 11:417-26 (2009). ICC/IF; Human. PubMed: 19622035
11. Mateizel I et al. Characterization of CD30 expression in human embryonic stem cell lines cultured in serum-free media and passaged mechanically. Hum Reprod 24:2477-89 (2009). PubMed: 19584135
12. Ullmann U et al. GSK-3-specific inhibitor-supplemented hESC medium prevents the epithelial-mesenchymal transition process and the up-regulation of matrix metalloproteinases in hESCs cultured in feeder-free conditions. Mol Hum Reprod 14:169-79 (2008). PubMed: 18263607
13. Lerou PH et al. Derivation and maintenance of human embryonic stem cells from poor-quality in vitro fertilization embryos. Nat Protoc 3:923-33 (2008). PubMed: 18451800
14. Fong H et al. Regulation of self-renewal and pluripotency by Sox2 in human embryonic stem cells. Stem Cells 26:1931-8 (2008). WB; Human. PubMed: 18388306
15. Van de Velde H et al. The four blastomeres of a 4-cell stage human embryo are able to develop individually into blastocysts with inner cell mass and trophectoderm. Hum Reprod 23:1742-7 (2008). ICC/IF; Human. PubMed: 18503052
16. Park IH et al. Disease-specific induced pluripotent stem cells. Cell 134:877-86 (2008). ICC/IF; Human. PubMed: 18691744
17. Cauffman G et al. Markers that define stemness in ESC are unable to identify the totipotent cells in human preimplantation embryos. Hum Reprod : (2008). PubMed: 18824471
18. Card DA et al. Oct4/Sox2-regulated miR-302 targets cyclin D1 in human embryonic stem cells. Mol Cell Biol 28:6426-38 (2008). ChIP; Human. PubMed: 18710938
19. Ullmann U et al. Epithelial-mesenchymal transition process in human embryonic stem cells cultured in feeder-free conditions. Mol Hum Reprod 13:21-32 (2007). PubMed: 17090644